Bextra Linked to Heart Attack, Stevens-Johnson Syndrome

Last Updated on June 26, 2017

Important Information

Attorneys working with are no longer investigating this matter. The information here is for reference only. A list of open investigations and lawsuits can be viewed here.

Comments |

At A Glance

This Alert Affects
If you have used Bextra as directed by a doctor and suffered a heart attack, stroke, or serious skin reactions, you may be entitled to compensation.
Use of Bextra has been shown to produce higher than normal cardiovascular events for patients. This includes heart attacks and strokes. It has also been linked to potentially life threatening skin conditions including Stevens Johnson Syndrome, toxic epidermal necrolysis, and erythema multiforme.
Additional Details
Bextra is prescription drug used to treat arthritis, menstrual cramps, and associated problems. It is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID) and helps reduce pain, swelling, and fever without causing stomach irritation.
On April 7, 2005, Pfizer removed Bextra from the market in response to pressure from the FDA.